Virtus Fund Advisers, LLC Veracyte, Inc. Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 3,609 shares of VCYT stock, worth $132,053. This represents 0.31% of its overall portfolio holdings.
Number of Shares
3,609
Previous 3,471
3.98%
Holding current value
$132,053
Previous $76,000
2.63%
% of portfolio
0.31%
Previous 0.27%
Shares
4 transactions
Others Institutions Holding VCYT
# of Institutions
270Shares Held
78.7MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$285 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$274 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$252 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$180 Million1.59% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.17MShares$116 Million0.44% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.62B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...